Latest filing published 15 Feb 2024 for Cytophage Technologies Ltd., €1,923.
Michael Graham appears in our data through filings on Cytophage Technologies Ltd. shares, published by SEDI. Over a trading history stretching from 2 February 2024 to 15 February 2024, the count stands at 5 filings.
No open-market sale appears; the market trades are 4 purchases worth €6,386. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Half of the purchases are above €1,824 and half below. No cluster: in 4 purchases, no other insider of the company bought within 30 days.
On 15 February 2024 came the latest disclosure, an open-market purchase for €1,923 in Cytophage Technologies Ltd. Publication is fast: at least half of the trades appear on SEDI on the same day. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations